Can a pretzel-shaped device rewrite the story of bladder cancer? In September 2025, the U.S. Food and Drug Administration (FDA) approved Inlexzo™ (formerly TAR-200), a novel intravesical gemcitabine delivery system developed by Johnson & Johnson for…
TrialX, in collaboration with investigators at the University of Iowa is proud to announce that the SAYSTOP Study App, developed to study antibiotic resistance using our remote data collection solution, has successfully completed enrollment. The “Study of…
The 15th annual DPHARM: Disruptive Innovations to Modernize Clinical Research (September 16–17, 2025, Philadelphia, PA) brought together senior clinical operations executives, patient advocates, and technology leaders to explore the future of clinical trials. AI, patient-centric trial…
We’re honored to share that TrialX’s global clinical trial finder now powers the ALS Network’s Trial Finder—an AI-driven platform designed to help individuals easily discover clinical trials focused on amyotrophic lateral sclerosis (ALS) and related motor neuron…
If you’ve ever thought clinical research was all charts and checklists, Crystal Bruner will quickly change your mind. She brings warmth, creativity, and just the right amount of introspection to a role that often stays behind…
Every day, across the world, researchers are working to develop new treatments, improve diagnostics, and better understand how we live with, manage, and overcome disease. These efforts are fueled by science—but they only move forward because…
Clinical Research Coordinators (CRCs) are often the first point of contact for participants, guiding them through every step of a study. From screening to consent management and recruitment to protocol compliance, CRCs handle a broad and…
